About Jory Bell
Form D filings for Manifold Biotechnologies from 2020 to 2024 list Jory Bell as director.
Jory Bell first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Jory Bell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jory Bell works with at each company, as listed on that company's latest Form D.
Manifold Biotechnologies, Inc. · Form D, Dec 3, 2024
GK
Gleb Kuznetsov
Chief Executive Officer and director
JH
Jeff Huber
Director
PO
Pierce Ogden
Executive officer and director
SK
Steven Kafka
Director
SH
Steven Holtzman
Director